Ausgabe 3/2012
Inhalt (14 Artikel)
Evidence-Based Medicine and the Selection of Lipid-Lowering Therapy in Type 2 Diabetes
Carlos A. Aguilar-Salinas, Roopa Mehta, Rita A. Gomez-Diaz
The Role of Combination Therapy in Type 2 Diabetes in the Post-ACCORD Era
Louis Kuritzky
Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
Muhammad A. Abdul-Ghani, Luke Norton, Ralph A. DeFronzo
Treatment of Type 2 Diabetes in the Elderly
Medha N. Munshi, Megumi Maguchi, Alissa R. Segal
A Review and Critical Analysis of Professional Societies’ Guidelines for Pharmacologic Management of Type 2 Diabetes Mellitus
Robert A. Vigersky
Glycemic Control and Cardiovascular Disease: What’s a Doctor to Do?
Preeti Kishore, Sharon H. Kim, Jill P. Crandall
Metformin Use Among Individuals at Risk for Type 2 Diabetes
Lewis H. Kuller
Is It Time to Screen for the Haptoglobin Genotype to Assess the Cardiovascular Risk Profile and Vitamin E Therapy Responsiveness in Patients with Diabetes?
Moshe Vardi, Andrew P. Levy
The Distinctive Nature of Atherosclerotic Vascular Disease in Diabetes: Pathophysiological and Morphological Insights
Rishi Puri, Yu Kataoka, Kiyoko Uno, Stephen J. Nicholls
Diagnosis of Coronary Artery Disease in Persons with Diabetes Mellitus
Nima Alipour, Nathan D. Wong, Shaista Malik
Diabetes Mellitus and Acute Coronary Syndrome: Lessons From Randomized Clinical Trials
Sanjum S. Sethi, Elias G. Akl, Michael E. Farkouh
Update on Diabetic Cardiomyopathy: Inches Forward, Miles to Go
Maggie N. Tillquist, Thomas M. Maddox
The Diagnosis and Management of Cerebrovascular Disease in Diabetes
Michael S. Phipps, Ania M. Jastreboff, Karen Furie, Walter N. Kernan